Trial NCT01382706

View at ClinicalTrials.gov 
Org. Study IDs: 4B-10-4
Secondary IDs: NCI-2011-01108

Last trial update was posted on 2018-05-16

MeSH Interventions

Docetaxel Lapatinib

MeSH Conditions

Carcinoma Carcinoma, Transitional Cell Urinary Bladder Neoplasms

Other Conditions

Recurrent Bladder Cancer Stage III Bladder Cancer Stage IV Bladder Cancer Transitional Cell Carcinoma of the Bladder

Stopping Reasons

Trial not progressing toward scientific goals

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID